Did you know that the successful pipeline of one of the most important pharmaceutical companies in the United States started in Europe, and scientists from Prague played a key role? Did you know that profound expertise in turning deep tech life science into a business, scale it, and go public in the US can be found in Prague since the late 80s of the previous century?If you want to know which US pharmaceutical companies' pipeline started in Prague, then listen to this Episode Number 25. I am delighted to host an...
Did you know that the successful pipeline of one of the most important pharmaceutical companies in the United States started in Europe, and scientists from Prague played a key role? Did you know that profound expertise in turning deep tech life science into a business, scale it, and go public in the US can be found in Prague since the late 80s of the previous century?
If you want to know which US pharmaceutical companies' pipeline started in Prague, then listen to this Episode Number 25. I am delighted to host an exceptional guest from one of the most beautiful cities in Europe. I will talk with Karel Kubias from i&i in Prague.
Karel studied organic chemistry and photochemistry at TH Merseburg, Germany, and holds an MBA in Healthcare Management (Auburn University program).
He gained his broad professional knowledge and skills during his 24 years in various management positions at multinational chemical and pharmaceutical company Merck KGaA. Between 2006 – 2015, Karel worked in executive positions – first as Managing Director of Merck spol. s r.o.. Prague and then as Regional sales director for the region EEMEA (Eastern Europe, Middle East & Africa) of Merck Millipore division, where he acquired further experience on the international level. He now supports i&i Prague as Director for Partnerships and Strategic Alliances.
i&i Prague is accelerating the proof-of-concept stage of projects in the fields of Medtech, Diagnostics, and Drug discovery. The company focuses on projects in the discovery, pre-seed, or seed phase with excellent innovative potential, which will benefit from the project-launching experience and networking skills developed by IOCB Tech over the last decade. Furthermore, the financial support provided by i&i Prague should significantly increase the appeal and value of a project for further licensees and/ or investors.
Youtube
Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Karel Kubias (https://www.linkedin.com/in/karelkubias/)
Organizations:
CS Life Science Invest (https://lnkd.in/eyhWK7H)
i&i Prague (https://www.linkedin.com/company/iniprague/)
IOCB Tech (https://www.linkedin.com/company/iocb-tto-s-r-o-/)
IOCB (https://www.linkedin.com/company/iocb-prague/)
Be part of our Network:
Subscribe here: https://mailchi.mp/e2467061ef75/lsg2g
Send us a text
Support the show
Join the Podcast Newsletter: Link
View more
